Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTRB1 | P17538 | 4/20 | 0.50 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.48 |
| ▸ | RPS6KA5 | O75582 | 1/20 | 0.48 |
| ▸ | RPS6KA4 | O75676 | 1/20 | 0.48 |
| ▸ | PRKACA | P17612 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | GSK3A | P49840 | 1/20 | 0.48 |
| ▸ | GSK3B | P49841 | 1/20 | 0.48 |
| ▸ | IRAK1 | P51617 | 1/20 | 0.48 |
| ▸ | PRKX | P51817 | 1/20 | 0.48 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.48 |
| ▸ | PRKG1 | Q13976 | 1/20 | 0.48 |
| ▸ | PKN2 | Q16513 | 1/20 | 0.48 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.48 |
| ▸ | SGK2 | Q9HBY8 | 1/20 | 0.48 |
| ▸ | CTSG | P08311 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3940642 | 0.86 | CTRB1 (0.53) | CTRB1ROCK2RPS6KA5RPS6KA4PRKACA | |
| SCHEMBL3941746 | 0.86 | CTRB1 (0.53) | CTRB1ROCK2RPS6KA5RPS6KA4PRKACA | |
| SCHEMBL29167801 | 0.86 | CTRB1 (0.53) | CTRB1ROCK2RPS6KA5RPS6KA4PRKACA | |
| SCHEMBL6342085 | 0.86 | CTRB1 (0.59) | CTRB1ROCK2RPS6KA5RPS6KA4PRKACA | |
| SCHEMBL6355600 | 0.83 | CTRB1 (0.50) | CTRB1ROCK2RPS6KA5RPS6KA4PRKACA | |
| SCHEMBL3132363 | 0.80 | CTRB1 (0.47) | CTRB1ROCK2RPS6KA5RPS6KA4PRKACA | |
| SCHEMBL15304889 | 0.80 | MEN1 (0.54) | CTRB1ROCK2RPS6KA5RPS6KA4PRKACA | |
| SCHEMBL10358851 | 0.79 | HTT (0.57) | CTRB1ROCK2RPS6KA5RPS6KA4PRKACA | |
| SCHEMBL3381007 | 0.79 | HTT (0.57) | CTRB1ROCK2RPS6KA5RPS6KA4PRKACA | |
| SCHEMBL5685800 | 0.78 | CTRB1 (0.73) | CTRB1ROCK2RPS6KA5RPS6KA4PRKACA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020046403-A1 | NOVEL PROCESS FOR THE PREPARATION OF ENANTIOPURE 3- ENANTIOPURE 3-AMINO TETRAHYDROFURAN AND ITS SALTS | MAJEED MUHAMMED (US) | 2020-03-05 | — | — | WO | disclosed |
| US-10421734-B1 | Process for the preparation of enantiopure 3-amino tetrahydrofuran and its salts | SAMI LABS LIMITED (IN) | 2019-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10421734-B1 | Process for the preparation of enantiopure 3-amino tetrahydrofuran and its salts | AASDHPPT, AAAS, AADAT | CTRB1 3706/4885ROCK2 4790/4885RPS6KA5 499/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.